综合癌症中心卵巢癌患者胚系基因检测转诊与完成的预测因素
该研究回顾性分析2014至2019年北卡罗来纳大学健康系统新诊断卵巢癌患者的病历数据,识别胚系基因检测转诊与完成的预测因素。459例患者中307例(67%)被转诊遗传咨询,285例(62%)完成检测;转诊患者完成检测的预测概率为0.83(95%CI:0.77-0.88),未转诊者为0.27(95%CI:0.18-0.35)。转诊率随邮政编码水平社会剥夺指数(SDI)升高而降低,且因肿瘤科医生不同而异;从诊断到检测结果的中位时间为137天(IQR:55-248天),该间隔每年预测缩短24.46天(95%CI:37.75-11.16)。
要点
- 459例新诊断卵巢癌患者中67%转诊遗传咨询,62%完成胚系检测。
- 转诊者完成检测的预测概率为0.83,未转诊者为0.27。
- 转诊率因肿瘤科医生不同而异,预测概率范围0.47至0.93。
核心结论
- 作者报告相对较高的胚系检测率及从诊断到结果时间的有望趋势,但存在肿瘤科医生和患者因素导致的差异。
- 作者建议探索自动化转诊、远程遗传咨询和样本采集、降低自付费用及教育干预。
研究设计与样本
- 回顾性研究,从北卡罗来纳大学健康系统2014年至2019年新诊断卵巢癌患者病历中提取临床和社会人口学数据。
- 使用多变量回归识别与遗传咨询转诊、胚系检测完成及诊断至检测结果时间相关的因素。
主要发现
- 307/459(67%)患者被转诊遗传咨询,285/459(62%)完成检测。
- 有转诊者完成检测的预测概率为0.83(95%CI:0.77-0.88),无转诊者为0.27(95%CI:0.18-0.35)。
- 邮政编码水平社会剥夺指数(SDI)第25百分位患者转诊预测概率为0.75(95%CI:0.69-0.82),第75百分位为0.67(95%CI:0.60-0.74)。
- 转诊因肿瘤科医生而异,预测概率范围从0.47(95%CI:0.32-0.62)到0.93(95%CI:0.85-1.00)。
- 从诊断到检测结果的中位时间为137天(IQR:55-248天),该间隔每年预测缩短24.46天(95%CI:37.75-11.16)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify predictors of referral and completion of germline genetic testing among newly diagnosed ovarian cancer patients, with a focus on geographic social deprivation, oncologist-level practices, and time between diagnosis and completion of testing. METHODS: Clinical and sociodemographic data were abstracted from medical records of patients newly diagnosed with ovarian cancer between 2014 and 2019 in the University of North Carolina Health System. Factors associated with referral for genetic counseling, completion of germline testing, and time between diagnosis and test results were identified using multivariable regression. RESULTS: 307/459 (67%) patients were referred for genetic counseling and 285/459 (62%) completed testing. The predicted probability of test completion was 0.83 (95% CI: 0.77-0.88) for patients with a referral compared to 0.27 (95% CI: 0.18-0.35) for patients without a referral. The predicted probability of referral was 0.75 (95% CI: 0.69-0.82) for patients at the 25th percentile of ZIP code-level Social Deprivation Index (SDI) and 0.67 (0.60-0.74) for patients at the 75th percentile of SDI. Referral varied by oncologist, with predicted probabilities ranging from 0.47 (95% CI: 0.32-0.62) to 0.93 (95% CI: 0.85-1.00) across oncologists. The median time between diagnosis and test results was 137 days (IQR: 55-248 days). This interval decreased by a predicted 24.46 days per year (95% CI: 37.75-11.16). CONCLUSIONS: We report relatively high germline testing and a promising trend in time from diagnosis to results, with variation by oncologist and patient factors. Automated referral, remote genetic counseling and sample collection, reduced out-of-pocket costs, and educational interventions should be explored.
引用
- Saylor KW, Fernandes EQ, Adams M, et al. Predictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center. Gynecol Oncol. 2024. PMID: 38599112. doi:10.1016/j.ygyno.2024.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。